Elan (ELN)

12.08 +0.04  +0.33%  May 21, 5:00PM
Add to Watchlists Create an Alert

Elan Cash from Investing Quarterly:

138.80M for March 31, 2013
View Full Chart

Elan Cash from Investing Quarterly Chart

    Elan Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 138.80M
    Dec. 31, 2012 -25.90M
    Sept. 30, 2012 -3.90M
    June 30, 2012 -43.20M
    March 31, 2012 376.20M
    Sept. 30, 2011 588.50M
    June 30, 2011 176.50M
    Dec. 31, 2010 -201.40M
    Sept. 30, 2010 -14.70M
    June 30, 2010 2.30M
    March 31, 2010 -2.20M
    Dec. 31, 2009 -0.40M
    Sept. 30, 2009 6.40M
    June 30, 2009 -1.80M
    March 31, 2009 -61.00M
    Dec. 31, 2008 -21.00M
    Sept. 30, 2008 -72.40M
    June 30, 2008 10.70M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
       
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro
    June 30, 2000 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    ELN Cash from Investing Quarterly Benchmarks

    Companies
    Biogen Idec 155.94M
    Theravance -45.01M
    GlaxoSmithKline -452.89M

    ELN Cash from Investing Quarterly Rankings

    Overall 98th percentile
    108 of 8002
    Sector 98th percentile
    7 of 684 in Healthcare
    Industry 98th percentile
    3 of 248 in Biotechnology

    ELN Cash from Investing Quarterly Range, Past 5 Years

    Minimum -201.40M Dec 2010
    Maximum 588.50M Sep 2011
    Average 47.31M